Celyad news and White Paper

Belgian cell therapy pioneer Celyad has just announced that their natural killer cell program dubbed THINK (THerapeutic Immunotherapy with NKR-2)…

The week ahead – week 18

The American Association of Clinical Endocrinologists (AACE) holds its Annual Meeting in Austin Geneva hosts the European Lung Cancer Conference…

The week ahead – week 11

Heron Therapeutics updates on FDA acceptance of NDA for Cinvanti (HTX-019) Immunogen will present initial biomarker data from 20-patient biopsy…

Positive Lynparza readout

AstraZeneca has just announced positive Breast cancer results from a head to head Phase III trial which compares its PARP…